[HTML][HTML] The use of sodium-glucose cotransporter 2 inhibitors and the incidence of uveitis in type 2 diabetes: a population-based cohort study

JF Chung, PJ Yang, CK Chang, CY Lee… - Archives of Medical …, 2024 - ncbi.nlm.nih.gov
Results There were 147 and 371 new uveitis episodes in the SGLT2 and control groups
after the follow-up period up to 5 years. The incidence of uveitis in the SGLT2 group (aHR …

The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction, diabetes and kidney function COMMENT

GHD Voordes, HJL Heerspink… - European Journal of …, 2022 - research.rug.nl
The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction,
diabetes and kidney function Page 1 University of Groningen The interplay between …

[HTML][HTML] Burden of Renal Dysfunction and Neurologic Complications in Hospitalized Pediatric Heart Failure Unrelated to Congenital Heart Disease: A Multicenter …

B Das, J Godown, SR Deshpande - Transplantology, 2023 - mdpi.com
Objectives: Limited data are available on renal dysfunction and neurologic complications in
heart failure in children, when the heart failure is not related to congenital heart disease …

Association between worsening renal function severity during hospitalization and low physical function at discharge: a retrospective cohort study of older patients with …

I Kubo, KP Izawa, N Kajisa, H Nakamura… - European Geriatric …, 2023 - Springer
Background The number of hospitalized older patients with chronic heart failure, chronic
kidney disease, and worsening renal function is rising in Japan. This study aimed to clarify …

Antagonistes du récepteur minéralocorticoïde-Une nouvelle option thérapeutique dans la maladie rénale diabétique

S Girerd, M Soulie, J Barrera-Chimal… - médecine …, 2023 - medecinesciences.org
La maladie rénale diabétique (MRD) et ses comorbidités cardiovasculaires représentent
des complications majeures chez les patients diabétiques. Au cours des deux dernières …

[HTML][HTML] Protective Effect of SGLT2 Inhibitor on D-Galactose-Induced Senescence in Mice and Its Mechanism

Z Ma, M Xu, K Jin, G Zhu, X Chen - Journal of Biosciences and Medicines, 2023 - scirp.org
Objective: To observe the cerebral protective effect of dagliflozin, a sodium-glucose co-
transport protein 2 (SGLT2) inhibitor, in aging mice and to explore its molecular mechanism …

Explore the possible pathway of improving liver and heart injury in diabetes nephropathy based on bioinformatics analysis

Y Yang, Q Wang, X Wang, X Wang - 2023 - researchsquare.com
Background This study explore the possible pathway of MicroRNA-130a, TXNIP, CD44 and
TGF-β1 improving liver and heart injury in diabetes nephropathy based on bioinformatics …

Diuretika

H Oßwald, B Mühlbauer - … -Report 2007: Aktuelle Daten, Kosten, Trends …, 2008 - Springer
Von den Diuretika werden hauptsächlich Schleifendiuretika und Thiazide verordnet.
Aldosteronantagonisten folgen mit deutlichem Abstand. Schleifendiuretika sind weiterhin …

[引用][C] A New Epoch in Treating Diseases of the Heart

JQ Purnell, SA Camacho - Journal of clinical lipidology, 2024 - lipidjournal.com
In any medical career, moments stand out when a previous treatment approach is no longer
acceptable and a new therapeutic era is ushered in. With the publication of the Diabetes …

[引用][C] Clinical application of Yang-Supplementing acupuncture therapy in the treatment of chronic heart failure combined with chronic kidney disease.

X Deng, W Wang, S Wen, F Jin - Asian Journal of Surgery, 2024 - europepmc.org
Clinical application of Yang-Supplementing acupuncture therapy in the treatment of chronic
heart failure combined with chronic kidney disease. - Abstract - Europe PMC Sign in | Create an …